Background: Melanosis is a rare, but well recognized late complication of some cases of metastatic melanoma. The precise pathogenesis is unclear. Most described cases report diffuse metastases and diffuse melanosis.
Objective: To present a case of localized melanosis secondary to locally metastatic melanoma without evidence of systemic involvement in a renal transplant patient.
Methods: Case report and literature review.
Results: We describe a case of localized melanosis in an immunocompromised patient without evidence of systemic metastases. The patient underwent limb perfusion and her immunosuppressive therapy has been stopped. The melanosis has not regressed; however, there has been no systemic involvement and her transplanted kidney is still functioning well.
Conclusion: To our knowledge this is the first report of this phenomenon in an immunocompromised host.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1046/j.1524-4725.2002.01139.x | DOI Listing |
J Cutan Pathol
October 2024
Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.
Skin Res Technol
September 2024
Department of Tuina, Affiliated Hospital of Changchun University of Traditional Chinese Medicine, Changchun, Jilin, P.R. China.
Cureus
August 2024
Department of Ophthalmology, Unidade Local de Saúde de São João, Porto, PRT.
Radiother Oncol
November 2024
QST Hospital, National Institutes for Quantum Science and Technology, Chiba, Japan.
Background And Purpose: No guidelines exist for the clinical target volume (CTV) and radiotherapy dose in sinonasal mucosal melanoma (SNMM). Thus, we aimed to determine the carbon-ion radiotherapy (CIRT) CTV and dose for SNMM.
Materials And Methods: In total, 135 patients with SNMM who received CIRT were reviewed.
Lasers Med Sci
August 2024
Mackay Memorial Hospital, Dermatology, No. 92, Sec. 2, Zhongshan N. Rd, Taipei, TW, Taiwan.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!